Premium
High metabolic N‐oxidation of voriconazole in a patient with refractory aspergillosis and CYP2C19* 17 /* 17 genotype
Author(s) -
Bennis Youssef,
Bodeau Sandra,
Bouquié Régis,
Deslandes Guillaume,
Verstuyft Céline,
Gruson Bérangère,
Andréjak Michel,
LemaireHurtel AnneSophie,
Chouaki Taieb
Publication year - 2015
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/bcp.12713
Subject(s) - voriconazole , galactomannan , aspergillosis , medicine , cyp2c19 , gastroenterology , therapeutic drug monitoring , posaconazole , pharmacokinetics , amphotericin b , antifungal drug , pharmacology , immunology , antifungal , cytochrome p450 , dermatology , metabolism
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom